An efficient protein production system via gene amplification on a human artificial chromosome and the chromosome transfer to CHO cells.
Animals
Antibodies, Monoclonal
/ genetics
CHO Cells
Chromosomes, Artificial, Human
Cricetulus
Genetic Vectors
Green Fluorescent Proteins
/ genetics
Humans
Matrix Attachment Regions
/ genetics
Nucleic Acid Amplification Techniques
Protein Engineering
/ methods
Recombinant Proteins
/ genetics
Vascular Endothelial Growth Factor A
/ immunology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 11 2019
18 11 2019
Historique:
received:
12
08
2019
accepted:
28
10
2019
entrez:
20
11
2019
pubmed:
20
11
2019
medline:
15
12
2020
Statut:
epublish
Résumé
Gene amplification methods play a crucial role in establishment of cells that produce high levels of recombinant protein. However, the stability of such cell lines and the level of recombinant protein produced continue to be suboptimal. Here, we used a combination of a human artificial chromosome (HAC) vector and initiation region (IR)/matrix attachment region (MAR) gene amplification method to establish stable cells that produce high levels of recombinant protein. Amplification of Enhanced green fluorescent protein (EGFP) was induced on a HAC carrying EGFP gene and IR/MAR sequences (EGFP MAR-HAC) in CHO DG44 cells. The expression level of EGFP increased approximately 6-fold compared to the original HAC without IR/MAR sequences. Additionally, anti-vascular endothelial growth factor (VEGF) antibody on a HAC (VEGF MAR-HAC) was also amplified by utilization of this IR/MAR-HAC system, and anti-VEGF antibody levels were approximately 2-fold higher compared with levels in control cells without IR/MAR. Furthermore, the expression of anti-VEGF antibody with VEGF MAR-HAC in CHO-K1 cells increased 2.3-fold compared with that of CHO DG44 cells. Taken together, the IR/MAR-HAC system facilitated amplification of a gene of interest on the HAC vector, and could be used to establish a novel cell line that stably produced protein from mammalian cells.
Identifiants
pubmed: 31740706
doi: 10.1038/s41598-019-53116-2
pii: 10.1038/s41598-019-53116-2
pmc: PMC6861226
doi:
Substances chimiques
Antibodies, Monoclonal
0
Recombinant Proteins
0
Vascular Endothelial Growth Factor A
0
enhanced green fluorescent protein
0
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16954Références
PLoS One. 2012;7(7):e41787
pubmed: 22844523
PLoS One. 2013 Oct 17;8(10):e75935
pubmed: 24146795
J Cell Biochem. 2007 Oct 1;102(2):515-29
pubmed: 17390337
Curr Opin Biotechnol. 2018 Jun;51:64-69
pubmed: 29223005
Biotechnol Bioeng. 2008 Sep 1;101(1):182-9
pubmed: 18454496
Trends Biotechnol. 2006 Mar;24(3):137-42
pubmed: 16460822
Gene Ther. 2011 Apr;18(4):384-93
pubmed: 21085194
PLoS One. 2015 Apr 07;10(4):e0120096
pubmed: 25849659
Biotechnology (N Y). 1990 Jul;8(7):662-7
pubmed: 1369995
Braz J Microbiol. 2016 Dec;47 Suppl 1:51-63
pubmed: 27838289
BMC Biotechnol. 2016 Jan 22;16:6
pubmed: 26800878
PLoS One. 2017 Sep 14;12(9):e0183315
pubmed: 28910287
PLoS One. 2007 Jan 17;2(1):e162
pubmed: 17225864
J Natl Cancer Inst. 2019 Jun 1;111(6):538-549
pubmed: 30859213
Biotechnol Bioeng. 2011 Oct;108(10):2434-46
pubmed: 21538334
Transgenic Res. 2015 Aug;24(4):717-27
pubmed: 26055730
J Hum Genet. 2018 Feb;63(2):145-156
pubmed: 29180645
Sci Rep. 2015 Feb 03;5:8201
pubmed: 25643913
Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30
pubmed: 22159888
J Clin Pharm Ther. 2018 Dec;43(6):925-930
pubmed: 30047144
Biotechnol Lett. 2005 Nov;27(21):1713-7
pubmed: 16247680
Biotechnol Bioeng. 2009 Oct 15;104(3):526-39
pubmed: 19544304
Appl Microbiol Biotechnol. 2016 Apr;100(8):3451-61
pubmed: 26936774
Biologicals. 2007 Jun;35(3):211-5
pubmed: 17071102
Biotechnol Bioeng. 1998 Apr 5;58(1):73-84
pubmed: 10099263
Cytotechnology. 2013 May;65(3):363-78
pubmed: 22907508
J Biosci Bioeng. 2015 Jul;120(1):78-84
pubmed: 25678240
Cytotechnology. 2000 Jul;33(1-3):83-8
pubmed: 19002814
Protein Expr Purif. 2011 Nov;80(1):41-6
pubmed: 21645621
PLoS One. 2012;7(12):e52990
pubmed: 23300841
J Hum Genet. 2011 Oct;56(10):727-33
pubmed: 21833006
J Biosci Bioeng. 2007 Jan;103(1):82-91
pubmed: 17298905
Biochem Biophys Res Commun. 2019 Jan 8;508(2):603-607
pubmed: 30509488
Biotechnol Prog. 2010 Sep-Oct;26(5):1400-10
pubmed: 20945494
Cell. 1998 May 1;93(3):321-4
pubmed: 9590165
PLoS One. 2015 Feb 23;10(2):e0116878
pubmed: 25706993
Biotechnol Prog. 2006 May-Jun;22(3):770-80
pubmed: 16739961
PLoS One. 2017 Apr 12;12(4):e0175585
pubmed: 28403180
Appl Microbiol Biotechnol. 2002 Dec;60(4):442-8
pubmed: 12466885
PLoS One. 2014 Jul 25;9(7):e103439
pubmed: 25061979
Biochem Biophys Res Commun. 2004 Aug 20;321(2):280-90
pubmed: 15358173
Nucleic Acids Res. 2019 Jun 20;47(11):5998-6006
pubmed: 31062017
Appl Microbiol Biotechnol. 2005 Nov;69(2):162-9
pubmed: 15818475